Table 2—

Changes in anthropometric, MRI, and metabolic variables

DO
DA
DR
Absolute%Absolute%Absolute%
Anthropometry
 Weight (kg)−10.0 ±3.9*11 ±3−11.1 ±4.4*11 ±4−10.0 ±3.0*12 ±4
 BMI (kg/m2)−4.0 ±1.4*11 ±3−4.2 ±1.2*11 ±4−3.9 ±1.0*12 ±4
 WHR−0.01 ±0.041 ±5−0.01 ±0.021 ±3−0.01 ±0.011 ±1
 Waist circumference (cm)−7.5 ±4.6*7 ±4−7.3 ±5.4*7 ±5−8.5 ±2.3*9 ±2
MRI
 Total fat (kg)−7.8 ±3.1*19 ±5−9.9 ±4.6*21 ±10−8.6 ±2.4*24 ±8
 Abdominal subcutaneous fat (kg)−1.3 ±0.6*19 ±7−1.6 ±0.8*22 ±10−1.7 ±0.7*29 ±11
  at L4-L5 (cm2)−82 ±66*15 ±15−60 ±22*22 ±10−26 ±11*19 ±6
 Visceral fat (kg)−0.65 ±0.37*29 ±11−0.61 ±0.41*31 ±18−0.42 ±0.21*31 ±9
  at L4-L5 (cm2)−51 ±21*37 ±11−39 ±24*29 ±16−19 ±16*24 ±15
 Skeletal muscle (kg)−1.1 ±0.8*5 ±3−0.6 ±1.12 ±4−0.4 ±1.12 ±5
 Intermuscular fat (kg)−0.22 ±0.19*17 ±12−0.38 ±0.40*24 ±26−0.12 ±0.14*10 ±12
Metabolic
 Fasting glucose (mmol/l)−0.1 ±0.41 ±8−0.1 ±0.52 ±9−0.1 ±0.42 ±8
 Fasting insulin (pmol/l)−48.1 ±45.5*27 ±28−17 ±395 ±36−33.0 ±38.9*19 ±29
 Glucose area (mmol · l−1 · 3 h−1)−1.0 ±2.05 ±11−1.0 ±1.85 ±10−1.8 ±2.5*9 ±11
 Insulin area (pmol · l−1 · 3 h−1)−328 ±549*17 ±36−445 ±490*23 ±36−321 ±354*17 ±20
 Insulin sensitivity index (ml · m–2 · min–1)31 ±30*9 ±836 ±39*11 ±1240 ±36*12 ±11
 Triglycerides (mmol/l)−0.52 ±1.5512 ±27−0.26 ±0.4911 ±31−0.35 ±0.8215 ±30
 Total cholesterol (mmol/l)−0.83 ±0.36*16 ±7−0.42 ±0.55*9 ±11−0.60 ±0.43*12 ±9
 LDL cholesterol (mmol/l)−0.55 ±0.49*16 ±17−0.28 ±0.429 ±14−0.34 ±0.50*10 ±16
 HDL cholesterol (mmol/l)−0.05 ±0.242 ±25−0.03 ±0.183 ±15−0.09 ±0.11*7 ±11
 Total-to-HDL cholesterol ratio−0.76 ±1.7110 ±19−0.17 ±0.624 ±13−0.21 ±0.614 ±10
 Apolipoprotein B (g/l)−0.11 ±0.09*10 ±8−0.17 ±0.14*17 ±14−0.16 ±0.13*14 ±10
 Apolipoprotein A (g/l)−0.01 ±0.175 ±2−0.14 ±0.2510 ±20−0.05 ±0.164 ±14
 Apolipoprotein B–to–LDL cholesterol ratio0.03 ±0.0110 ±17−0.03 ±0.056 ±120.02 ±0.072 ±18
  • Data are means ±SD.

  • *

    * Significant within-group change (P < 0.017, paired t test with Bonferonni adjustments).